Cardiovascular Problems in Peritoneal Dialysis Patients: A Short Overview

Lameire N. , Vanholder R.C. , Van Loo A. , Lambert M.C. , Vijt D. , Van Bockstaele L. Cardiovascular diseases in peritoneal dialysis patients: The size of the problem. Kidney Int. 1996; 50(Suppl 56): S28–36.

Maiorca R. , Cancarini G.C. , Zubani R. , Camerini C. , Manili L. , Brunori G. CAPD viability: A long-term comparison with hemodialysis. Perit Dial Int. 1996; 16: 276–87.

Locatelli F. , Marcelli D. , Conte F. , Limido A. , Lonati F. , Malberti F. 1983 to 1992: Report on regular dialysis and transplantation in Lombardy. Am J Kidney Dis. 1995; 25: 196–205.

Lameire N. , Bernaert P. , Lambert M.C. , Vijt D. Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int. 1994; 46(Suppl 48): S31–8.

Viglino G. , Cancarini G.C. , Catizone L. , Cocchi R. , De Vecchi A. , Lupo A. Ten years experience of CAPD in diabetics: Comparison of results with non-diabetics. Nephrol Dial Transplant. 1994; 9: 1443–8.

Canada-U.S.A. (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis. Association with clinical out comes. J Am Soc Nephrol. 1996; 7: 198–207.

Genestier S. , Hedelin G. , Schaffer P. , Faller B. Prognostic factors in CAPD patients: A retrospective study of a 10-year period. Nephrol Dial Transplant. 1995; 10: 1905–11.

Harnett J.D. , Foley R.N. , Kent G.M. , Barre P.E. , Murray D. , Parfrey P.S. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int. 1995; 47: 884–90.

Foley R.N. , Parfrey P.S. , Harnett J.D. , Kent G.M. , O'Dea R. , Murray D.C. Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol. 1998; 9: 267–76.

Burton P.R. , Walls J. Selection-adjusted comparison of life-expectancy of patients on continuous ambulatory peritoneal dialysis, hemodialysis, and renal transplantation. Lancet. 1987; 1: 1115–18.

Gault M.H. , Longerich L. , Prabshakaran V. , Purchase L. Ischemic heart disease, serum cholesterol and apolipoproteins in CAPD. ASAIO Trans. 1991; 37: M513–14.

Parfrey P.S. , Foley R.N. , Harnett J.D. , Kent G.M. , Murray D.C. , Barre P.E. The outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant. 1996; 11: 1277–85.

Foley R.N. , Parfrey P.S. , Harnett J.D. , Kent G.M. , Martin C.J. , Murray D.C. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995; 47: 186–92.

Hüting J. , Kramer W. , Reitinger J. , Kuhn K. , Wizemann V. , Schutterle G. Cardiac structure and function in continuous ambulatory peritoneal dialysis: Influence of blood purification and hypercirculation. Am Heart J. 1990; 119: 334–52.

Hüting J. , Kramer W. , Reittinger J. , Kuhn K. , Schutterle G. , Wizemann V. Abnormal diastolic left ventricular filling by pulsed Doppler echocardiography in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol. 1991; 36: 21–8.

Buonchristiani U. , Gamberi G. , Misuri S. , Carobi C. , Giombini L. , Di Paolo N. Diastolic left ventricular malfunction in CAPD patients. In: Ota K. , Maher J. , Winchester J. , Hirszel P. , eds. Current Concepts in Peritoneal Dialysis. Amsterdam: Excerpta Medica; 1992: 681–6.

Tabacchi G.C. , Castiglioni A. , Lola P. , Giangrande A. Echocardiographic evaluation of left ventricular function in patients on CAPD [Abstract]. Perit Dial Bull. 1987; 7(Suppl 2): S75.

Mousson C. , Tanter Y. , Chalopin J.M. , Rebibou J.M. , Dentan G. , Morelon P. Traitement de l'insuffisance cardiaque congestive au stade terminal par dialyse péritonéale continue. Evolution a long terme. Presse Med. 1988; 17: 1617–20.

Deligiannis A. , Paschalidou E. , Sakellariou G. , Vargemezis V. , Geleris P. , Kontopoulos A. Changes in left ventricular anatomy during haemodialysis, continuous ambulatory peritoneal dialysis and after renal transplantation. Proc EDTA-ERA. 1984; 21: 185–9.

Leenen F.H.H. , Smith D.L. , Khanna R. , Oreopoulos D.G. Changes in left ventricular hypertrophy and function in hypertensive patients started on continuous ambulatory peritoneal dialysis. Am Heart J. 1985; 110: 102–6.

Eisenberg M. , Prichard S. , Barré P. , Pat ton R. , Hutchinson T. , Sniderman A. Left ventricular hypertrophy in endstage renal disease on peritoneal dialysis. Am J Cardiol. 1987; 60: 418–19.

Peer G. , Korzets A. , Hochhauzer E. , Eschcar Y. , Blum M. , Avram A. Cardiac arrhythmia during chronic ambulatory peritoneal dialysis. Nephron. 1987; 45: 192–5.

McLenachan J.M. , Dargie H.J. Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Am J Hypertens. 1990; 3: 735–40.

Canziani M.E. , Saragosa M.A. , Draibe S.A. , Barbieri A. , Ajzen H. Risk factors for the occurrence of cardiac arrhythmias in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1993; 13(Suppl 2): S409–11.

Canziani M.E. , Cendoroglo Neto M. , Saragoça M.A. , Cassiolato M.A. , Ramos O.L. , Ajzen H. Hemodialysis versus continuous ambulatory peritoneal dialysis: Effects on the heart. Artif Organs. 1995; 19: 241–4.

Rottembourg J. Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int. 1993; 43(Suppl 40): S106–10.

Tzamaloukas A.H. , Saddler M.C. , Murata G.H. Symptomatic fluid retention in patients on continuous peritoneal dialysis. J Am Soc Nephrol. 1995; 6: 198–206.

Lameire N. The impact of residual renal function on the adequacy of peritoneal dialysis. Nephron. 1997; 77: 13–28.

Heimbürger O. , Waniewski J. , Werynski A. , Tranæus A. , Lindholm B. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int. 1990. 38: 495–506.

Selgas R. , Bajo M.A. , Del Peso G. , Jimenez C. Preserving the peritoneal membrane in long-term peritoneal dialysis patients. Semin Dial. 1995; 8: 326–32.

Martinez-Vea A. , Bardaji A. , Garcia C. , Ridao C. , Richart C. , Oliver J.A. Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis. Am J Kidney Dis. 1992; 19: 353–7.

Fellner S.K. , Lang R.M. , Neumann A. , Korcarz C. , Borow K.M. Cardiovascular consequences of correction of the anemia of renal failure with erythropoietin. Kidney Int. 1993; 44: 1309–15.

Morris K.P. , Skinner J.R. , Hunter S. , Coulthard M.G. Short term correction of anaemia with recombinant human erythropoietin and reduction of cardiac output in end stage renal failure. Arch Dis Child. 1993; 68: 644–8.

Foley R.N. , Parfrey P.S. , Harnett J.D. , Kent G.M. , Murray D.C. , Barre P.E. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int. 1996; 49: 1379–85.

Saldanha L.F. , Weiler E. , Gonick H.C. Effect of continuous ambulatory peritoneal dialysis on blood pressure control. Am J Kidney Dis. 1993; 21: 184–8.

Charra B. , Calemard E. , Ruffet M. , Chazot C. , Terrat J.C. , Vanel T. Survival as an index of adequacy of dialysis. Kidney Int. 1992; 41: 1286–91.

United States Renal Data System. USRDS 1992 Annual Data Report. IV. Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis. 1992; 5(Suppl 2): 32–8.

Iseki K. , Miyasato F. , Tokuyama K. , Nishime K. , Uehara H. , Shiohira Y. Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int. 1997; 51: 1212–17.

Iseki K. , Kawazoe N. , Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int. 1993; 44: 115–19.

Spiegel D.M. , Breyer J.A. Serum albumin: A predictor of long-term outcome in peritoneal dialysis patients. Am J Kidney Dis. 1994; 23: 283–5.

Acchiardo S.R. , Moore L.W. , La Tour P.A. Malnutrition as the main factor in the morbidity and mortality of hemodialysis patients. Kidney Int. 1983; 24(Suppl 16): 199–203.

Kopple J.D. Effect of malnutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis. 1994; 24: 1002–9.

Foley R.N. , Parfrey P.S. , Hamett J.D. , Kent G.M. , Murray D.C. , Barre P.E. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol. 1996; 7: 728–36.

Lowrie E.G. , Laird N.M. , Parker T.F. , Sargent J.A. Effect of the hemodialysis prescription on patient morbidity. Report from the National Co-operative Dialysis Study. N Engl J Med. 1981; 305: 157–65.

Foley R.N. , Parfrey P.S. , Harnett J.D. , Kent G.M. , Hu L. , O'Dea R. Hypocalcemia, morbidity, and mortality in end-stage renal disease. Am J Nephrol. 1996; 16: 386–93.

Massry S.G. , Smorgorzewski M. Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia. Semin Nephrol. 1994; 14: 219–31.

Lacour B. , Basile C. , Drüeke T. , Funck-Brentano J.L. Parathyroid function and lipid metabolism in the rat. Miner Electrolyte Metab. 1982; 7: 157–65.

Stefenelli T. , Mayr H. , Bergler-Klein J. , Globits S. , Woloszczuk W. , Niederle B. Primary hyperparathyroidism: Incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med. 1993; 95: 197–202.

Totao R.D. , Lena Vega G.L. , Grundy S.M. Mechanisms and treatment of dyslipidemia of renal diseases. Curr Opin Nephrol Hypertens. 1993. 2: 784–90.

Auguet T. , Senti M. , Rubies-Prat J. , Pelegri A. , Pedro Botet J. , Nogues X. Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: Influence of apolipoprotein(a) genetic polymorphism. Nephrol Dial Transplant. 1993; 8: 1099–103.

Webb A.T. , Reaveley D.A. , O'Donnell M. , O'Connor B. , Seed M. , Brown E.A. Lipoprotein (a) in patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 1993; 8: 609–13.

Koch M. , Thomas B. , Tschope W. , Ritz E. Survival and predictors of death in dialysed diabetic patients. Diabetologia. 1993; 36: 1113–17.

Cressman M.D. , Heyka R.J. , Paganini E.P. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation. 1992; 86: 475–82.

Goldwasser P. , Michel M.A. , Collier J. , Mittman N. , Fein P.A. , Gusik S.A. Prealbumin and lipoprotein(a) in hemodialysis: Relationships with patient and vascular access survival. Am J Kidney Dis. 1993; 22: 215–25.

Bostom A.G. , Lathrop L. Hyperhomocysteinemia in endstage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int. 1997; 52: 10–20.

Gupta A. , Robinson K. Hyperhomocysteinemia and end stage renal disease. J Nephrol. 1997; 10: 77–84.

Bachmann J. , Tepel M. , Raidt H. , Riezler R. , Graefe U. , Zappia V. Hyperhomocysteinemia and the risk of vascular disease in hemodialysis patients. J Am Soc Nephrol. 1995; 6: 121–5.

Robinson K. , Gupta A. , Dennis V. , Arheart K. , Chaudhary D. , Green R. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in endstage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation. 1996; 94: 2743–8.

Hultberg B. , Andersson A. , Sterner G. Plasma homocys teine in renal failure. Clin Nephrol. 1993; 40: 230–4.

Kim S. , Hirose S. , Tamura H. , Nagasawa R. , Tokushima H. , Mitarai T. Hyperhomocysteinemia as a possible role for atherosclerosis in CAPD patients. In: Khanna R. , ed. Advances in Peritoneal Dialysis. Toronto: Peritoneal Dialysis Publications, 1994; 10: 282–5.

Maggi E. , Bellazzi R. , Falaschi F. , Frattoni A. , Perani G. , Finardi G. Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis? Kidney Int. 1994; 45: 876–83.

Sutherland W.H. , Walker R.J. , Ball M.J. , Stapley S.A. , Robertson M.C. Oxidation of low density lipoproteins from patients with renal failure or renal transplants. Kidney Int. 1995; 48: 227–36.

Schulz T. , Schiffl H. , Scheithe R. , Hrboticky N. , Lorenz R. Preserved antioxidative defense of lipoproteins in renal failure and during hemodialysis. Am J Kidney Dis. 1995; 25: 564–71.

Maggi E. , Bellazzi R. , Gazo A. , Seccia M. , Bellomo G. Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis. Kidney Int. 1994; 46: 869–76.

Hüting J. Progression of valvular sclerosis in end-stage renal disease treated by long-term peritoneal dialysis. Clin Cardiol. 1992; 15: 745–50.

Muirhead N. , Bargman J. , Burgess E. , Jindal K.K. , Levin A. , Nolin L. , Parfrey P. Evidence-based recommendations for the clinical use of recombinant human erythropoietin. Am J Kidney Dis. 1995; 26(Suppl 1): S1–24.

Lewis E.J. , Hunsicker L.G. , Bain R.D. , Rohde R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993; 329: 1456–62.

Maschio G. , Alberti D. , Janin G. , Locatelli F. , Mann J.F. , Motolese M. Effect of the angiotensin-converting- enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med. 1996; 334: 939–45.

Schneider R.E. , Martas P. , Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA. 1996; 275: 1507–13.

London G.M. , Pannier B. , Guerin A.P. , Marchais S.J. , Safar M.E. , Cuche J.L. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation. 1994; 90: 2786–96.

Bostom A.G. , Shemin D. , Lapane K.L. , Hume A.L. , Yoburn D. , Nadeau M.R. High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int. 1996; 49: 147–52.

The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987; 316: 1429–35.

The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991; 325: 293–302.

Yusuf B. , Pepine C.J. , Gares C. , Pouleur H. , Salem D. , Kostis J. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 1992; 340: 1173–8.

Pfeffer M.A. , Braunwald E. , Moyé L.A. , Basta L. , Brown E.J. , Cuddy T.E. Effect of captopril on mortality and morbidity inpatients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1992; 327: 669–77.

Oster J.R. , Materson B.J. Renal and electrolyte complications of congestive heart failure and effects of therapy with angiotensin-converting enzyme inhibitors. Arch Intern Med. 1992; 152: 704–10.

The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997; 336: 525–33.

Cohn J.H. , Archibald D.G. , Ziesche S. , Franciosa J.A. , Hartson W.E. , Tristani F.E. Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986; 314: 1547–52.

Zaremski D.G. , Nolan P.E. , Srack M.K. , Lui C.Y. Metaanalysis of the use of low dose beta blockers in idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol. 1996; 77: 1247–50.

Mckinnie J.J. , Bourgeois R.J. , Husserl F.E. Longterm therapy for heart failure with continuous ambulatory peritoneal dialysis. Arch Int Med. 1985; 145: 1128–9.

Rubin J. , Ball R. Continuous ambulatory peritoneal dialysis as treatment of severe congestive heart failure in the face of chronic renal failure. Report of eight cases. Arch Int Med. 1986; 146: 1533–5.

Konig P.S. , Lhotta K. , Kronenberg F. , Joannidis M. , Herold M. CAPD: A successful treatment in patients suffering from therapy-resistant congestive heart failure. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in Peritoneal Dialysis. Toronto: Peritoneal Dialysis Bulletin, 1991; 7: 97–101.

Ko W. , Kreiger K.H. , Isom O.W. Cardiopulmonary bypass procedures in dialysis patients. Ann Thorac Surg. 1993; 55: 677–84.

Rinehart A.L. , Herzog C.A. , Collins A.J. , Flack J.M. , Ma J.Z. , Opsahl J.A. A comparison of coronary angioplasty and coronary artery bypass grafting in chronic dialysis patients. Am J Kidney Dis. 1995; 25: 281–90.